|
1
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hashibe M, Brennan P, Chuang SC, et al:
Interaction between tobacco and alcohol use and the risk of head
and neck cancer: Pooled analysis in the International Head and Neck
Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev.
18:541–550. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Howlader N, Noone AM, Krapcho M, et al:
SEER Cancer Statistics Review, 1975–2010. National Cancer
Institute; Bethesda, MD: http://seer.cancer.gov/csr/1975_2010/based on
November 2012 SEER data submission, posted to the SEER web site.
April. 2013
|
|
4
|
Báez A: Genetic and enviromental factors
in head and neck cancer genesis. J Environ Sci Health C Environ
Carcinog Ecotoxicol Rev. 26:174–200. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gleich LL and Salamone FN: Molecular
genetics of head and neck cancer. Cancer Control. 9:369–378.
2002.PubMed/NCBI
|
|
6
|
Demokan S, Suoglu Y, Demir D, et al:
Microsatellite instability and methylation of the DNA mismatch
repair genes in head and neck cancer. Ann Oncol. 17:995–999. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pereira-Leal JB and Seabra MC: Evolution
of the Rab family of small GTP-binding proteins. J Mol Biol.
313:889–901. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zerial M and McBride H: Rab proteins as
membrane organizers. Nat Rev Mol Cell Biol. 2:107–117. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deneka M, Neeft M and van der Sluijs P:
Regulation of membrane transport by rab GTPases. Crit Rev Biochem
Mol Biol. 38:121–142. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pfeffer S and Aivazian D: Targeting Rab
GTPases to distinct membrane compartments. Nat Rev Mol Cell Biol.
5:886–896. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jordens I, Marsman M, Kuijl C and Neefjes
J: Rab proteins, connecting transport and vesicle fusion. Traffic.
6:1070–1077. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schwartz SL, Cao C, Pylypenko O, Rak A and
Wandinger-Ness A: Rab GTPases at a glance. J Cell Sci.
120:3905–3910. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Somsel Rodman J and Wandinger-Ness A: Rab
GTPases coordinate endocytosis. J Cell Sci 113 Pt. 2:183–92.
2000.
|
|
14
|
Vetter IR and Wittinghofer A: The guanine
nucleotide-binding switch in three dimensions. Science.
294:1299–1304. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Goldenring JR, Shen KR, Vaughan HD and
Modlin IM: Identification of a small GTP-binding protein, Rab25,
expressed in the gastrointestinal mucosa, kidney and lung. J Biol
Chem. 268:18419–18422. 1993.PubMed/NCBI
|
|
16
|
He H, Dai F, Yu L, et al: Identification
and characterization of nine novel human small GTPases showing
variable expressions in liver cancer tissues. Gene Expr.
10:231–242. 2002.PubMed/NCBI
|
|
17
|
Casanova JE, Wang X, Kumar R, et al:
Association of Rab25 and Rab11a with the apical recycling system of
polarized Madin-Darby canine kidney cells. Mol Biol Cell. 10:47–61.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Kumar R, Navarre J, et al:
Regulation of vesicle trafficking in madin-darby canine kidney
cells by Rab11a and Rab25. J Biol Chem. 275:29138–29146. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Agarwal R, Jurisica I, Mills GB and Cheng
KW: The emerging role of the RAB25 small GTPase in cancer. Traffic.
10:1561–1568. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng KW, Lahad JP, Gray JW and Mills GB:
Emerging role of RAB GTPases in cancer and human disease. Cancer
Res. 65:2516–2519. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mitra S, Cheng KW and Mills GB: Rab25 in
cancer: A brief update. Biochem Soc Trans. 40:1404–1408. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng KW, Lahad JP, Kuo WL, et al: The
RAB25 small GTPase determines aggressiveness of ovarian and breast
cancers. Nat Med. 10:1251–1256. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan Y, Xin XY, Chen BL and Ma X: Knockdown
of RAB25 expression by RNAi inhibits growth of human epithelial
ovarian cancer cells in vitro and in vivo. Pathology. 38:561–567.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Tao X, Jia L, et al: Knockdown of
RAB25 promotes autophagy and inhibits cell growth in ovarian cancer
cells. Mol Med Rep. 6:1006–1012. 2012.PubMed/NCBI
|
|
25
|
Zhang J, Wei J, Lu J, et al:
Overexpression of Rab25 contributes to metastasis of bladder cancer
through induction of epithelial-mesenchymal transition and
activation of Akt/GSK-3β/Snail signaling. Carcinogenesis.
34:2401–2408. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Calvo A, Xiao N, Kang J, et al:
Alterations in gene expression profiles during prostate cancer
progression: Functional correlations to tumorigenicity and
down-regulation of selenoprotein-P in mouse and human tumors.
Cancer Res. 62:5325–5335. 2002.PubMed/NCBI
|
|
27
|
Wang W, Goswami S, Lapidus K, et al:
Identification and testing of a gene expression signature of
invasive carcinoma cells within primary mammary tumors. Cancer Res.
64:8585–8594. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mor O, Nativ O, Stein A, et al: Molecular
analysis of transitional cell carcinoma using cDNA microarray.
Oncogene. 22:7702–7710. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Natrajan R, Williams RD, Hing SN, et al:
Array CGH profiling of favourable histology Wilms tumours reveals
novel gains and losses associated with relapse. J Pathol.
210:49–58. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng JM, Ding M, Aribi A, et al: Loss of
RAB25 expression in breast cancer. Int J Cancer. 118:2957–2964.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Goldenring JR and Nam KT: Rab25 as a
tumour suppressor in colon carcinogenesis. Br J Cancer. 104:33–36.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Amornphimoltham P, Rechache K, Thompson J,
et al: Rab25 regulates invasion and metastasis in head and neck
cancer. Clin Cancer Res. 19:1375–1388. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grosshans BL, Ortiz D and Novick P: Rabs
and their effectors: Achieving specificity in membrane traffic.
Proc Natl Acad Sci USA. 103:11821–11827. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cheng KW, Lu Y and Mills GB: Assay of
Rab25 function in ovarian and breast cancers. Methods Enzymol.
403:202–215. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sheach LA, Adeney EM, Kucukmetin A, et al:
Androgen-related expression of G-proteins in ovarian cancer. Br J
Cancer. 101:498–503. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tong M, Chan KW, Bao JY, et al: Rab25 is a
tumor suppressor gene with antiangiogenic and anti-invasive
activities in esophageal squamous cell carcinoma. Cancer Res.
72:6024–6035. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cheng JM, Volk L, Janaki DK, Vyakaranam S,
Ran S and Rao KA: Tumor suppressor function of Rab25 in
triple-negative breast cancer. Int J Cancer. 126:2799–2812.
2010.PubMed/NCBI
|
|
39
|
Bigelow RL, Williams BJ, Carroll JL, et
al: TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231
breast cancer cells and alters expression of a subset of cancer
promoting genes in vivo distinct from those observed in vitro.
Breast Cancer Res Treat. 117:31–44. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cheng KW, Agarwal R, Mitra S, et al: Rab25
increases cellular ATP and glycogen stores protecting cancer cells
from bioenergetic stress. EMBO Mol Med. 4:125–141. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Caswell PT, Spence HJ, Parsons M, White
DP, Clark K, Cheng KW, Mills GB, Humphries MJ, Messent AJ, Anderson
KI, et al: Rab25 associates with alpha5beta1 integrin to promote
invasive migration in 3D microenvironments. Dev Cell. 13:496–510.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lapierre LA, Caldwell CM, Higginbotham JN,
Avant KM, Hall J, Beauchamp RD and Goldenring JR: Transformation of
rat intestinal epithelial cells by overexpression of Rab25 is
microtubule dependent. Cytoskeleton (Hoboken). 68:97–111. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tang BL: Is Rab25 a tumor promoter or
suppressor-context dependency on RCP status? Tumor Biol.
31:359–361. 2010. View Article : Google Scholar
|
